1998
DOI: 10.1677/joe.0.1570033
|View full text |Cite
|
Sign up to set email alerts
|

Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells

Abstract: The neuropeptide galanin is widely distributed in the gastrointestinal tract and exerts several inhibitory effects, especially on intestinal motility and on insulin release from pancreatic -cells. The presence of galanin fibres not only in the myenteric and submucosal plexus but also in the mucosa, prompted us to investigate the regulatory role of galanin, and its mechanism of action, on the secretion of the insulinotropic hormone glucagon-like peptide-1 (GLP-1). Rat ileal cells were dispersed through mechanic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
13
0

Year Published

2001
2001
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 39 publications
2
13
0
Order By: Relevance
“…These findings are in line with reported effects of galanin in humans, which include a robust inhibition of gastrointestinal motility together with suppression of several gut peptides including PYY and GLP1 but not GIP (135). Galanin is likely to act via a G i -coupled, pertussis-sensitive galanin receptor (134). Interestingly, recent publications reported significantly elevated plasma galanin levels in patients with obesity and diabetes (136,137).…”
Section: Gut Microbiota Host Defense and Eec Signalingsupporting
confidence: 87%
See 1 more Smart Citation
“…These findings are in line with reported effects of galanin in humans, which include a robust inhibition of gastrointestinal motility together with suppression of several gut peptides including PYY and GLP1 but not GIP (135). Galanin is likely to act via a G i -coupled, pertussis-sensitive galanin receptor (134). Interestingly, recent publications reported significantly elevated plasma galanin levels in patients with obesity and diabetes (136,137).…”
Section: Gut Microbiota Host Defense and Eec Signalingsupporting
confidence: 87%
“…Galanin is widely expressed in the ENS and, along with somatostatin, is another inhibitor of EEC secretion. In isolated perfused rat ileum, galanin inhibited GIP-stimulated GLP1 release (132); in vitro, galanin inhibited the secretion of several gut hormones including CCK and GLP1 (133,134). These findings are in line with reported effects of galanin in humans, which include a robust inhibition of gastrointestinal motility together with suppression of several gut peptides including PYY and GLP1 but not GIP (135).…”
Section: Gut Microbiota Host Defense and Eec Signalingsupporting
confidence: 82%
“…Several model systems have been developed for the study of GLP-1 secretion in vitro, including partially purified canine or rat L-cells prepared by elutriation (19,20), cultured fetal rat intestinal cells (21), and GLP-1-secreting cell lines such as GLUTag (22), STC-1 (23), and NCI-H716 (24). GLUTag cells were derived from a colonic tumor taken from a transgenic mouse expressing SV40 large T antigen under the control of the proglucagon promoter and secrete GLP-1 in response to a range of physiological stimuli (25).…”
Section: Studying Pathways Involved In Glp-1 Releasementioning
confidence: 99%
“…These preparations have a maximum L-cell content of ϳ30% and have been used to show that GLP-1 secretion is enhanced by activators of PKA and PKC. Such preparations have also been used to demonstrate that GLP-1 secretion is inhibited by the neurotransmitter galanin, acting through a disopyramide-sensitive pathway that might involve K ATP channel opening (27).…”
mentioning
confidence: 99%